Noteworthy

Jul 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
What India's latest census tells us about current and future pharma opportunities.
Jun 30, 2011
By Pharmaceutical Executive Editors
Find out how pharma can find new drug candidates and refill the pipeline in this episode of Pharma Faceoff. Watch now.
Jun 10, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
In our latest podcast, Chris Garabedian, CEO at AVI BioPharma, discusses his company's $291 million contract with the Defense Department, and how RNA-based therapeutics are being used to combat infectious diseases.
Jun 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Suggestions for testing new ways of addressing difficult issues of risk
Jun 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Now that government payers are turning to pharma to bridge budgetary shortfalls it's best to think long-term
Jun 01, 2011
Pharmaceutical Executive
To decide on a course of treatment, patients need to be told the truth straight up
Jun 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Successful negotiations require a willingness to take risks and an ability to adapt
Jun 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Meet 2011's Emerging Pharma Leaders—Can these 30 trendsetters build competitive scale from scarcity?
Jun 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Part II of The Avoca Group's 2011 CRO survey on clinical development outsourcing relationships
Jun 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
With Yankee stadium as the backdrop, Pharm Exec convened its annual panel of eight business development experts to crack the bat on best practice in licensing and M&A for the year ahead.
native1_300x100
lorem ipsum